A Dose-response Evaluation of the SQ Tree SLIT-tablet Using an Environmental Exposure Chamber
Status:
Completed
Trial end date:
2016-04-01
Target enrollment:
Participant gender:
Summary
The trial is a phase II, randomised, parallel-group, double-blind, placebo-controlled
multi-site trial conducted in Canada. Before the start of treatment, the subjects will
undergo baseline birch and oak Environmental Exposure Chamber sessions. The treatment
duration is 24 weeks. The subjects will undergo birch Environmental Exposure Chamber sessions
after 8, 16 and 24 weeks of treatment and an oak Environmental Exposure Chamber session after
24 weeks of treatment.